Predictor factors for the development of arterial hypertension following heart transplantation

Clinical Transplantation

Volumn 22, Issue 6, 2008, Pages 760-764

  Sánchez lázaro, Ignacio J ^a,b   Martínez dolz, Luis ^a   Almenar bonet, Luis ^a   Moro lópez, José A ^a   Agüero, Jaime ^a   Ortiz martínez, Víctor ^a   Izquierdo, María Teresa ^a   Salvador, A ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b NONE   (Spain)

Author keywords

Arterial hypertension; Heart transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; DEFLAZACORT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS;

ADULT; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; HEART TRANSPLANTATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SMOKING;

ADULT; ANTIHYPERTENSIVE AGENTS; CARDIOMYOPATHIES; FEMALE; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES;

EID: 56349110005     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2008.00875.x     Document Type: Article

References (21)

1. Ozdogan E, Banner N, Fitzgerald M, Musumeci F, Khaghani A, Yacoub M. Factors influencing the development of hypertension after heart transplantation. J Heart Transplant 1990: 9: 548.
2. Ozduran V, Yamani MH, Chuang HH et al. Survival beyond 10years following heart transplantation: The Cleveland Clinic Foundation Experience. Transplant Proc 2005: 37: 4509.
3. Starling RC, Cody RJ. Cardiac transplant hypertension. Am J Cardiol 1990: 65: 106.
4. Frohlich ED, Ventura HO, Ochsner JL. Arterial hypertension after orthotopic cardiac transplantation. J Am Coll Cardiol 1990: 15: 1102.
5. Ventura HO, Malik FS, Mehra MR, Stapleton DD, Smart FW. Mechanisms of hypertension in cardiac transplantation and the role of cyclosporine. Curr Opin Cardiol 1997: 12: 375.
6. Lindenfeld J, Page RL, Zolty R et al. Drug therapy in heart transplant reciCient: Part III: common medical problems. Circulation 2005: 111: 113.
7. Reeves RA, Saphiro AP, Thompson ME, Johnsen AM. Loss of nocturnal decline in blood pressure after cardiac transplantation. Circulation 1986: 73: 401.
8. Jenkins GH, Singer DR. Hypertension in thoracic transplant recipients. J Hum Hypertens 1998: 12: 813-23.
9. European Society of Hypertension-European Society of Cardiology Guidelines for the management of arterial Hypertension. Guidelines Committee. 2003
10. Martínez-Dolz L, Almenar L, Arnau MA et al. Análisis de los factores que pueden influir en la aparición del fallo agudo del corazón transplantado. Rev Esp Cardiol 2003: 56: 168.
11. Moro JA, Martínez-Dolz L, Almenar L et al. Impact of diabetes mellitus on heart transplant recipients. Rev Esp Cardiol 2006: 59: 1033.
12. Béji S, Abderrahim E, Kaaroud H et al. Risk factors of arterial hypertension after renal transplantation. Transplant Proc 2007: 39: 2580.
13. Amrose JA, Barua RS. Pathophysiology of cigarette smoking and cardiovascular disease: An update. J Am Coll Cardiol 2004: 43: 1731.
14. Takayama H, Nathens AB, Merry H et al. Is pre-transplant vascular disease a risk factor for mortality and morbidity after heart transplantation? Eur J Cardiothorac Surg 2007: 31: 457.
15. Erdoes LS, Hunter GC, Venerus BJ et al. Prospective evaluation of peripheral vascular disease in heart transplant recipients. J Vasc Surg 1995: 22: 434.
16. Crespo-Leiro MG. Calcineurin inhibitors in heart transplantation. Transplant Proc 2005: 37: 4108.
17. Patel JK, Kobashigawa. Cardiac transplant experience with cyclosporine. Transplant Proc 2004: 36 (Suppl 2S): 323S.
18. Sander M, Victor RG. Hypertension after cardiac transplantation: pathophysiology and management. Curr Opin Nephrol Hypertens 1995: 4: 443.
19. Abramowicz D, Del Carmen Rial M, Vitko S et al. Cyclosporine Withdrawal Study Group Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen: Results of a five-year, prospective, randomized study. J Am Soc Nephrol 2005: 16: 2234.
20. Eisen HJ. Hypertension in heart transplant recipients: More than just cyclosporine. J Am Coll Cardiol 2003: 41: 433.
21. Kunst H, Thompson D, Hodson M. Hypertension as a marker for later development of end-stage renal failure after lung and heart-lung transplantation: A cohort study. J Heart Lung Transplant 2004: 23: 1182.